Pediatric Cancer Clinical Trials

32 studies are recruiting for pediatric cancer in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies now recruiting

  1. Digital Art Therapy for Young Cancer Survivors

    This is a single-site, single-arm, interventional study assessing the feasibility of the ARTCan Therapy Application (App) and whether it is an acceptable means of administering art therapy to young adult cancer survivors. The ARTCan Therapy App guides participants through a 6-week digital art thera…

    Stage
    Not phased
    Ages
    18 to 25
    Site
    Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
    Run by
    UNC Lineberger Comprehensive Cancer Center
  2. Biomarkers of Resiliency In Childhood Cancer Surgery

    This observational study is to better understand how children and their families recover after the stress of major surgery for cancer so that investigators can create ways to improve resilience during recovery. The main questions it aims to answer are: 1. Can information obtained from patients and …

    Stage
    Not phased
    Ages
    3 to 25
    Site
    Mayo Clinic, Rochester, Minnesota
    Run by
    Mayo Clinic
  3. Ovarian Tissue Cryopreservation in Post Pubertal (OTC-Post Pubertal)

    The purpose of this study is to safely remove ovarian tissue in pediatric patients, who are at risk for infertility from their medical treatment, for freezing for future restoration of fertility and hormone function.

    Stage
    Not phased
    Ages
    Up to 30
    Site
    Ann &Robert H Lurie Children's Hospital, Chicago, Illinois
    Run by
    Erin Rowell
  4. Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)

    To evaluate the ability of a multidisciplinary and multisite group, the Pediatric Evolutionary Tumor Board (pedsETB), to develop additional therapeutic strategies in patients without curative options or with suboptimal outcomes.

    Stage
    Not phased
    Ages
    Any age
    Site
    Connecticut Children's Medical Center, Hartford, Connecticut
    Locations
    3 in total
    Run by
    H. Lee Moffitt Cancer Center and Research Institute
  5. Lurbinectedin in FET-Fused Tumors

    The purpose of this study is to find out if a drug called lurbinectedin (the "study drug") is safe and effective at treating people with recurrent or relapsed solid tumors, including Ewing sarcoma.

    Stage
    Phase 1
    Ages
    10 and older
    Site
    Cedars-Sinai Medical Center, Los Angeles, California
    Locations
    6 in total
    Run by
    Children's Hospital of Philadelphia
  6. Psychological Benefits of a Normalized Camping Experience for Children With Cancer

    Background: * Cancer has an enormous impact on the psychological and social well-being of the family unit. The life-threatening connotations of cancer single out the ill child from his peer/family group as one who is different, and often unable to maintain a normal lifestyle. Physical sequelae of c…

    Stage
    Not phased
    Ages
    7 to 25
    Site
    National Institutes of Health Clinical Center, Bethesda, Maryland
    Run by
    National Cancer Institute (NCI)
  7. Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

    This study will evaluate BCB-276, an investigational B7-H3-targeted Chimeric Antigen Receptor (CAR) T cell therapy, in children and young adults with diffuse intrinsic pontine glioma (DIPG). DIPG is a rare and aggressive brain tumor with limited treatment options. CAR T cell therapy uses a patient'…

    Stage
    Phase 2
    Ages
    1 to 26
    Site
    Seattle Children's Hospital, Seattle, Washington
    Locations
    6 in total
    Run by
    BrainChild Bio, Inc
  8. Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

    Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical resection is radioactive iodine (RAI) therapy. However, less than a quarter of patients with lung metastases will achieve…

    Stage
    Phase 2
    Ages
    2 to 25
    Site
    Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
    Locations
    5 in total
    Run by
    Children's Hospital of Philadelphia
  9. Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients

    Pediatric cancer survivors have increased infection-related morbidity and mortality. This study will evaluate immune dysfunction following cancer directed systemic therapy completion, with attention to clinical relevance and infection rate in this population compared to healthy siblings, when appli…

    Stage
    Phase 2
    Ages
    2 to 21
    Site
    Levine Cancer Institute, Charlotte, North Carolina
    Run by
    Wake Forest University Health Sciences
  10. LCI-PED-NOS-EXER-001: Exercise in Pediatric Oncology Patients

    The purpose of this study is to see if there are physical and emotional benefits to participating in a structured exercise regimen for those who are ages 2-25, are newly diagnosed with a blood or solid tumor cancer, and are currently undergoing or will begin cancer treatment.

    Stage
    Not phased
    Ages
    2 to 25
    Site
    Levine Children's Hospital, Charlotte, North Carolina
    Run by
    Wake Forest University Health Sciences
  11. Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer

    It is critical to provide accessible evidence-based psychosocial support to parents and caregivers of children with cancer (PCCC) in order to mitigate individual and family-level psychosocial risks. This effectiveness trial evaluates an eHealth intervention for English- and Spanish-speaking (PCCC) …

    Stage
    Not phased
    Ages
    Any age
    Site
    Nemours Children's Health, Delaware, Wilmington, Delaware
    Locations
    3 in total
    Run by
    Nemours Children's Clinic
  12. Response to Influenza Vaccination in Pediatric Oncology Patients

    Influenza infection occurring during oncologic treatment or following hematopoietic cell transplantation (HCT) is associated with increased risk of morbidity in the form of lower respiratory tract infection (LRTI) and mortality relative to otherwise healthy patients. The study participants have bee…

    Stage
    Not phased
    Ages
    Up to 18
    Site
    St. Jude Children's Research Hospital, Memphis, Tennessee
    Run by
    St. Jude Children's Research Hospital
  13. LIFE Cancer Survivorship Database for Pediatric Cancer

    The purpose of this study is to develop a mechanism for utilizing the comprehensive clinical database of childhood cancer survivors at Childrens Hospital Los Angeles (CHLA) for research purposes. Using clinical information obtained from follow-up visits of childhood cancer survivors, the database w…

    Stage
    Not phased
    Ages
    Any age
    Site
    Children's Hospital Los Angeles, Los Angeles, California
    Run by
    Children's Hospital Los Angeles
  14. Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells

    The objective of this study is to utilize all donated pediatric tumor tissues and cells obtained from autopsy to prospectively develop novel patient derived orthotopic xenograft (PDOX) mouse models as well as in vitro cell culture model systems for pediatric cancers, and also provide tissue samples…

    Stage
    Not phased
    Ages
    Any age
    Site
    Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois
    Run by
    Ann & Robert H Lurie Children's Hospital of Chicago
  15. Multisite Implementation of COMPRENDO

    COMPRENDO (ChildhOod Malignancy Peer Research NavigatiOn) is a multi-site randomized clinical trial (RCT) that uses a Hybrid Type 1 design, to test the effects of a clinical intervention on patient-level outcomes, while exploring multilevel implementation factors that can inform real-world setting …

    Stage
    Not phased
    Ages
    18 and older
    Site
    Children's of Alabama/University of Alabama at Birmingham, Birmingham, Alabama
    Locations
    4 in total
    Run by
    University of California, San Diego
  16. Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients

    This is a phase I/II study to evaluate the safety of combining intravenous (IV) atezolizumab and bevacizumab every three weeks, with daily oral cyclophosphamide and pharmacokinetic (PK)-guided sorafenib in children and adolescent and young adults (AYA) with relapsed or refractory solid malignancies…

    Stage
    Phase 1
    Ages
    Up to 30
    Site
    St. Jude Children's Research Hospital, Memphis, Tennessee
    Locations
    2 in total
    Run by
    St. Jude Children's Research Hospital
  17. Video Inspired Discussions About Ethical Outcomes in Pediatrics

    The goal of this clinical trial is to learn if the VIDEO-PEDS intervention works to improve Goals of Care communication between clinicians and parents of children with cancer. The main questions it aims to answer are: Does the intervention improve Goals of Care documentation? Does it improve patien…

    Stage
    Not phased
    Ages
    Any age
    Site
    Children's of Alabama at Birmingham, Birmingham, Alabama
    Locations
    4 in total
    Run by
    Massachusetts General Hospital
  18. UNC Childhood, Adolescent, and Young Adult Cancer Cohort

    Purpose: This study aims to create a registry of childhood, adolescent, and young adult patients with cancer (<40 years-old at cancer diagnosis), entitled the 'UNC Childhood, Adolescent, and Young Adult Cancer Cohort' (UNC-CAYACC). This resource will serve to support cancer outcomes research among …

    Stage
    Not phased
    Ages
    1 to 39
    Site
    University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
    Run by
    UNC Lineberger Comprehensive Cancer Center
  19. Development and Evaluation of a Screening Approach for Sexual Dysfunction in AYA Patients With and Surviving Childhood Cancer

    Prior research determined adolescent and young adult-aged childhood cancer survivor (AYA-CCS) and medical provider acceptability of the SexFS Brief in a controlled research setting. Development of an acceptable, effective, and feasible screening approach will result in improved recognition of SD in…

    Stage
    Not phased
    Ages
    15 to 24
    Site
    Childrens Hospital Colorado, Aurora, Colorado
    Locations
    2 in total
    Run by
    University of Colorado, Denver
  20. Feasibility and Acceptability of Internet-based Parent-child Interaction Therapy (I-PCIT) in Pediatric Cancer

    This study is being done to learn whether a telehealth intervention called "Internet-Based Parent Child Interaction Therapy," or I-PCIT," can help parents improve the child's behavior if the child currently or previously went through cancer treatment. Parents who choose to be in this study will com…

    Stage
    Not phased
    Ages
    Any age
    Site
    Johns Hopkins All Children's Hospital, St. Petersburg, Florida
    Run by
    Johns Hopkins All Children's Hospital
  21. Massage Impact on Sleep in Pediatric Oncology

    This study aims to determine the impact of massage therapy for pediatric patients receiving intensive chemotherapy or stem cell transplant (SCT).

    Stage
    Not phased
    Ages
    12 to 21
    Site
    Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
    Locations
    2 in total
    Run by
    Children's Hospital of Philadelphia
  22. Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma

    This study aims to evaluate the efficacy of Laser Interstitial Thermal Therapy (LITT) in treating recurrent or progressive, low-grade gliomas (LGG) in pediatric, adolescent and young adult patients.

    Stage
    Not phased
    Ages
    2 to 25
    Site
    University of California, San Francisco, San Francisco, California
    Run by
    University of California, San Francisco
  23. Shareholder-driven Co-design and Piloting of Spanish Educational Videos About High Yield Pediatric Oncology Topics

    Families of children with cancer who speak languages other than English experience inequalities in healthcare, but little research has been done on solutions to improve care for these families. This study will partner parents with medical interpreters and clinicians to create educational videos abo…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Children's Hospital Colorado, Aurora, Colorado
    Run by
    University of Colorado, Denver
  24. PediRISE Feasibility

    The goal of this research study is to learn whether investigators can successfully give the PediRISE program to families-in other words, whether most families are interested in participating in a study about the PediRISE program, including a 50-50 chance of receiving standard usual care, and a 50-5…

    Stage
    Not phased
    Ages
    Up to 17
    Site
    University of California San Francisco, San Francisco, California
    Locations
    4 in total
    Run by
    Dana-Farber Cancer Institute
  25. Cancer Care Companion

    This study invites parents of children with cancer to use an electronic health record (EHR)-based communication tool, called the Cancer Care Companion, and assess the acceptability, appropriateness, and feasibility of the tool.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Washington University School of Medicine/Saint Louis Children's Hospital, St Louis, Missouri
    Run by
    Washington University School of Medicine

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.